[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341056-105":59,"doc-detail-341056-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","expression-of-inflammation-depending-on-the-stage-of-cervical-cancer-research-article","Expression of Inflammation Depending on the Stage of Cervical Cancer - Research Article","","Cervical cancer remains a major global health burden and is closely associated with chronic inflammation. This study evaluates systemic inflammation expression in patients with cervical cancer and tests whether specific systemic inflammation markers provide prognostic thresholds for cervical cancer presence and advanced disease stage. Serum cytokines and related markers (IFN-β, IFN-γ, IL-1β, IL-2, IL-6, IL-10, IL-12p70, LCN2, TREM-1, TNF-α) were measured in 94 patients and 88 controls.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/expression-of-inflammation-depending-on-the-stage-of-cervical-cancer-research-article/341056/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/expression-of-inflammation-depending-on-the-stage-of-cervical-cancer-research-article/341056.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What systemic inflammation markers were evaluated in this study?","Question",{"text":113,"@type":114},"The study measured serum concentrations of IFN-β, IFN-γ, IL-1β, IL-2, IL-6, IL-10, IL-12p70, LCN2, TREM-1, and TNF-α.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was cervical cancer stage compared in the analysis?",{"text":118,"@type":114},"Advanced-stage disease was grouped as III–IV, and early-stage disease as I–II, then odds ratios were calculated for marker thresholds between these groups.",{"name":120,"@type":111,"acceptedAnswer":121},"Which markers were identified as predictors of cervical cancer and advanced-stage disease?",{"text":122,"@type":114},"IL-6, TREM-1, and LCN2 at specified levels could predict cervical cancer, while IL-6 and LCN2 could predict increased chance of advanced-stage (III–IV) cervical cancer.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},341056,1790829157,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","medicina  \nArticle  \nExpression of Inflammation Depending on the Stage of Cervical Cancer  \nAgne Vitkauskaite 1, Daiva Urboniene 2, Joana Celiesiute 1, Kristina Jariene 1, Saulius Paskauskas 1, Daiva Vaitkiene 1 and Astra Vitkauskiene 2, *  \nCitation: Vitkauskaite, A.; Urboniene, D.; Celiesiute, J.; Jariene, K.;  \nPaskauskas, S.; Vaitkiene, D.; Vitkauskiene, A. Expression of Inflammation Depending on the Stage of Cervical Cancer. Medicina 2024, 60,  \n349. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)medicina60030349  \nAcademic Editors: Tullio Golia D’Augè and Giorgia Perniola  \nReceived: 25 January 2024  \nRevised: 14 February 2024  \nAccepted: 16 February 2024  \nPublished: 20 February 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Obstetrics and Gynaecology, Medical Academy, Lithuanian University of Health Sciences, Eiveniu Str. 2, LT-50161 Kaunas, Lithuania; [agne.vitkauskaite@lsmu.lt](agne.vitkauskaite@lsmu.lt) (A.V.); [joana.celiesiute@lsmu.lt](joana.celiesiute@lsmu.lt) (J.C.); [kristina.jariene@lsmu.lt](kristina.jariene@lsmu.lt) (K.J.); [saulius.paskauskas@lsmu.lt](saulius.paskauskas@lsmu.lt) (S.P.); [daiva.vaitkiene@lsmu.lt](daiva.vaitkiene@lsmu.lt) (D.V.)  \n2 Department of Laboratory Medicine, Medical Academy, Lithuanian University of Health Sciences, Eiveniu Str. 2, LT-50161 Kaunas, Lithuania; [daiva.urboniene@lsmu.lt](daiva.urboniene@lsmu.lt)  \n* Correspondence: [astra.vitkauskiene@lsmu.lt](astra.vitkauskiene@lsmu.lt)  \nAbstract: Background and Objectives: Cervical cancer (CC) remains a major public health problem, ranking as the fourth most common cause of cancer incidence and mortality in women globally. The development of CC is believed to be closely related to chronic inflammation. Thus, we aimed to evaluate the expression of systemic inflammation in patients with CC and to determine the threshold prognostic value of the systemic inflammation markers for CC and its advanced stage. Materials and Methods: 182 participants were recruited: 94 histology-proven patient with CC and 88 healthy women with NILM confirmed by liquid-based cytology test. The pre-treatment serum concentrations of cytokines, including IFN-β, IFN-γ, IL-1β, IL-2, IL-6, IL-10, IL-12p70, LCN2, TREM-1, and TNF-α, were determined for all study patients. Results: The odds ratio (OR) of having IL-6 concentration >17.4 pg/mL in the CC group compared to control patients was 11.4 (95% CI: 4.897–26.684); that of having TREM-1 concentration >355.6 pg/mL was 5.9 (95% CI: 2.257–15.767); and that of having LCN2 concentration >23,721.5 pg/mL was 3.4 (95% CI: 1.455–8.166) . The odds ratio (OR) of having IL-6 concentration >28.7 pg/mL in advanced-stage CC (III–IV stage) compared to early-stage CC (I–II stage) was 2.921 (95% CI: 1.06–8.045), and that of having LCN2 concentration >25,640.0 pg/mL was 4.815 (95% CI: 1.78–13.026) . Conclusions: The pre-treatment serum inflammation markers IL-6, TREM-1, and LCN2 at specified levels could be used as predictors of cervical cancer, and IL-6 and LCN2 as predictors of an increased chance of advanced-stage (III–IV stages) cervical cancer. Patients with cervical cancer had expressed systemic inflammation, and expression of inflammation elevated the chance of having CC and advanced-stage disease.  \nKeywords: cervical cancer; inflammatory markers; interleukin-6; lipocalin-2; stages of cervical cancer; TREM-1  \n1. Introduction  \nCervical cancer (CC) remains a major public health problem, ranking as the fourth most common cause of cancer incidence and mortality in women globally [1] . CC is the most commonly diagnosed cancer in 23 countries worldwide and the leading c","cbCaihzg9iD9n3kX","https://ap.wps.com/l/cbCaihzg9iD9n3kX","pdf",301489,"English","# Introduction\n## Inflammation and cervical cancer background\n# Materials and Methods\n## Study participants and marker measurement\n# Results\n## Odds ratios by marker thresholds and cancer stage\n# Conclusions\n## Prognostic value of IL-6, TREM-1, and LCN2","[{\"question\":\"What systemic inflammation markers were evaluated in this study?\",\"answer\":\"The study measured serum concentrations of IFN-β, IFN-γ, IL-1β, IL-2, IL-6, IL-10, IL-12p70, LCN2, TREM-1, and TNF-α.\"},{\"question\":\"How was cervical cancer stage compared in the analysis?\",\"answer\":\"Advanced-stage disease was grouped as III–IV, and early-stage disease as I–II, then odds ratios were calculated for marker thresholds between these groups.\"},{\"question\":\"Which markers were identified as predictors of cervical cancer and advanced-stage disease?\",\"answer\":\"IL-6, TREM-1, and LCN2 at specified levels could predict cervical cancer, while IL-6 and LCN2 could predict increased chance of advanced-stage (III–IV) cervical cancer.\"}]","Expression of Inflammation Depending on the Stage of Cervical Cancer - Research Article | PDF",1790040110,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c2aa9066ec368e21f5020ed3a76546d3.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/72290f2fd888a5dc05dbb54906da45e6.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e6de5f79d5c28936d5154343e4494af.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bb0aa0f73edf0a21bad6d3f18188ad32.webp",980,1385]